Mike Baldzicki

Many innovative ideas can become obscured when communicated, which was a significant challenge for Patient Blood Management #PBM as it was introduced to benefit those suffering from #anemia, in hopes of enabling surgery without the use of donated blood upon leaving the ER (Emergency Room). The PBM educational approach supports bloodless surgical procedures. To reduce this obscurity, we are simplifying the message and increasing awareness, benefiting #researchers, manufacturers, and healthcare practitioners. Most importantly, we are enhancing the patient experience and raising public awareness. We are confident that many global organizations, healthcare providers, and blood management surgical equipment manufacturers will support our efforts as we continue to be pioneers in building a bridge of engagement for public access, which will benefit this field of medicine. Remember our medical icons, just in case one day you need direction to the OR. #Bloodlines #BBTS #Blood #SABM

6

The recent FTC report highlights the lack of transparency and potential anti-competitive practices within the PBM industry, dominated by a few big PBMs. However, APC wants to commend the smaller, independent PBMs for their open networks and partnerships with independent pharmacies. These actions are not just commendable, but they also prove that pharmacy benefit solutions can be flexible, transparent, and cost-effective without compromising patient care or competition. APC, as a key player in the industry, seeks out and works with these innovative PBMs, reassuring our benefit partners that we are actively fostering a more diverse and transparent marketplace. https://lnkd.in/e9a-MHMF

2

Very happy to share these highly credible recommendations by American Pharmacists about the OTC brands they trust the most - This list will really help consumers know which brands to choose when trying to decide for themselves. Happy to partner with Newsweek once again on this influential list. #Newsweek #PharmacistRecommendations #OTCbrands

10

1 Comment

Expandingpharmacist'sist’s role As demand for healthcare services in the United States continues to surpass capacity, new distribution methods are urgently needed. One approach involves using non-physician practitioners to reduce high wait times and cost difficulties for low-income patients. Diversification of responsibilities and workforce development can help improve population healthcare efficiency. Pharmacists, for example, have progressed from medicine dispensing to pharmaceutical therapy management and other healthcare services. In fact, many pharmacists have been successfully integrated with healthcare teams to enhance patient outcomes and develop novel healthcare delivery models.

11

2 Comments

Read the latest blog from our Chief Executive, Chad Worz, PharmD, BCGP, FASCP Fighting PBMs. https://lnkd.in/e4FDTFVy #blog #Pharmacists

12

1 Comment

Looking for an exit strategy? KARE Rx supports aggressive timelines for partners seeking to transition out, ensuring a maximized return on investment. Plan your exit with confidence. KARE Rx offers tailored support to optimize your timeline. ⏱️💼 #karerxpartners #independentpharmacy #pharmacysupports #localpharmacy #pharmaowners #communitypharmacy #pharmacist #pharmacyfirst

10

PBM reform, if handled correctly, will ultimately help reduce the cost of prescription medications to consumers — in part — by mandating improved pricing transparency and regulating certain practices within the industry. At UnitedRX, we support those efforts. . Read the full article: https://lnkd.in/e9UKkfhN . . #PharmacyBenefitManagers #PBM #PBMReform #LTC #longtermcare #pharmacy #medication #medicationcost

4

Our formulary management and connected enterprise model is making an impact. Here's what plan members have to say about their experience. https://cvs.co/3UqFnOR #MemberExperience #Biosimilars

13

Medication therapy management (MTM) is a key part of a successful clinical pharmacy strategy. But it goes beyond Star Ratings and pharmacy spend. MTM is one of the best ways to build strong, lasting relationships between pharmacists and patients. Over time, these relationships lead to better care and better health outcomes. Check out our recent article to learn more about how MTM plays a role in the relationships between pharmacists and their patients: https://hubs.ly/Q02wHc-90 #RevolutionizingPharmacy #MTM #HealthOutcomes #ValueBasedCare

7

RESPONSE OF ALLIANCE FOR PHARMACY COMPOUNDING CEO SCOTT BRUNNER TO ELI LILLY’S ASSERTION THAT COMPOUNDING PHARMACIES NEED TO BE PUNISHED May 15, 2024   In its May 14 statement on settlement of litigation with certain med spas, Eli Lilly lumps legitimate pharmacy compounding by state-licensed pharmacies with drug counterfeiters and says that compounding pharmacies “put patients at risk” by selling “unsafe products” and should be punished. What utter, self-serving nonsense.    Perhaps the Lilly folks need to re-read the Food, Drug & Cosmetic Act. Compounding is authorized in federal and state law and has been a necessary therapeutic option in the U.S. for generations. It’s essential when a prescriber judges there’s no appropriate FDA-approved drug for a patient or the appropriate FDA-approved drug is not available.    Maybe they should be reminded that compounding pharmacies are sourcing tirzepatide API from the very same FDA-registered manufacturers that media report Lilly has used.   Or maybe they just need a refresher on the regulatory framework in which compounding pharmacies operate, including the sterile compounding standards of the U.S. Pharmacopeia, which are enshrined in the pharmacy laws in the states.    Oh, and Lilly’s settlement with med spas that their statement purported to be about? Those aren’t compounding pharmacies, folks.   Best to remember that it’s Lilly that is unable to supply its life-enhancing drug to patients right now. So who exactly is putting those patients at risk?    That’s why if we want to talk about who deserves punishment– I’d prescribe a hard whack across the knuckles and a lesson in truth-telling – it’s Lilly for issuing such a crass, misleading statement.

41

2 Comments

Find out if your #biopharma sales force is calling on the right HCPs at the proper frequency with our GAPPS® assessment, which statistically evaluates the #productivity and #efficiency of HCP targets & call plans.   #pharmaceuticals #biotechnology #medicaldevices #lifesciences #innovation #motivation #consulting #sales #compensation #strategy #business https://lnkd.in/gfb4epC

12

1 Comment

Wondering what treatment options exist for your consumers living with Tardive Dyskinesia (TD)? Watch Genoa’s recent webinar for insights into treatment options, covered medications, clinical outcomes and more.

32

The recent removal of the 100% #AMPcap resulted in some interesting market dynamics. But what is AMP Cap, and why is it important to #plansponsors and manufacturers? When we chatted with Jessin Joseph, PharmD (Senior Director, PBA Services) he explained the history behind AMP Cap, new developments in the wake of the #InflationReductionAct, and how the market has reacted to those changes (among many other topics, like #M3P). Listen to the full episode here: https://okt.to/EHjsdc

79

2 Comments